Cargando…
Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study
INTRODUCTION: Mortality and morbidity related to traumatic brain injuries still remain high in patients. Many authors reported the importance of Selenium in maintaining the integrity of brain functions. This fact is supported by clinical evidence that therapy with selenium supplementation could help...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987113/ https://www.ncbi.nlm.nih.gov/pubmed/29875918 http://dx.doi.org/10.11604/pamj.2018.29.36.10945 |
_version_ | 1783329055684165632 |
---|---|
author | Belatar, Bahia Laidi, Fatna Abidi, Abdelah El Eljaoudi, Rachid Mamouch, Fouzia Kabbaj, Saad Maazouzi, Wajdi |
author_facet | Belatar, Bahia Laidi, Fatna Abidi, Abdelah El Eljaoudi, Rachid Mamouch, Fouzia Kabbaj, Saad Maazouzi, Wajdi |
author_sort | Belatar, Bahia |
collection | PubMed |
description | INTRODUCTION: Mortality and morbidity related to traumatic brain injuries still remain high in patients. Many authors reported the importance of Selenium in maintaining the integrity of brain functions. This fact is supported by clinical evidence that therapy with selenium supplementation could help patients suffering from brain disorders like neurodegenerative diseases. The aim of our study was to assess the relationship between Selenium concentration in serum and evolution of comatose patients with severe traumatic brain injury, in the first week of admission, and the correlation between selenium and C-reactive protein. METHODS: This case-control study was conducted with 64 comatose patients with TBI, in the Department of Anesthesiology and Reanimation, IbnSina University Hospital and Hospital of specialties in Rabat-Morocco, and healthy volunteers recruited in Blood transfusion center of Rabat. Blood sampling was collected from TBI patients, in the first week (3h after admission and each 48h during one week), and from healthy volunteers one time. Concentration of Se in serum was determined by electrochemical atomic absorption spectrometry. Statistical analysis was performed using Statistical software (SPSS) and the cases and controls were compared using the Mann-Whitney U test. A P-value < 0.05 was considered to be statistically significant. RESULTS: Comparison selenium concentration in the first day (D0), third day (D2) and fifth day according to the death and survival statue in patients did not show statistical significance (p > 0.05). Selenium concentration of D0 in patients and Selenium concentration in control group also did not show statistical significance (p > 0.05). Similarly, we did not report a correlation between selenium and C-reactive protein. CONCLUSION: According to our data selenium and CRP may not play a role in progression of coma state in patients with severe traumatic brain injury. |
format | Online Article Text |
id | pubmed-5987113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-59871132018-06-06 Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study Belatar, Bahia Laidi, Fatna Abidi, Abdelah El Eljaoudi, Rachid Mamouch, Fouzia Kabbaj, Saad Maazouzi, Wajdi Pan Afr Med J Research INTRODUCTION: Mortality and morbidity related to traumatic brain injuries still remain high in patients. Many authors reported the importance of Selenium in maintaining the integrity of brain functions. This fact is supported by clinical evidence that therapy with selenium supplementation could help patients suffering from brain disorders like neurodegenerative diseases. The aim of our study was to assess the relationship between Selenium concentration in serum and evolution of comatose patients with severe traumatic brain injury, in the first week of admission, and the correlation between selenium and C-reactive protein. METHODS: This case-control study was conducted with 64 comatose patients with TBI, in the Department of Anesthesiology and Reanimation, IbnSina University Hospital and Hospital of specialties in Rabat-Morocco, and healthy volunteers recruited in Blood transfusion center of Rabat. Blood sampling was collected from TBI patients, in the first week (3h after admission and each 48h during one week), and from healthy volunteers one time. Concentration of Se in serum was determined by electrochemical atomic absorption spectrometry. Statistical analysis was performed using Statistical software (SPSS) and the cases and controls were compared using the Mann-Whitney U test. A P-value < 0.05 was considered to be statistically significant. RESULTS: Comparison selenium concentration in the first day (D0), third day (D2) and fifth day according to the death and survival statue in patients did not show statistical significance (p > 0.05). Selenium concentration of D0 in patients and Selenium concentration in control group also did not show statistical significance (p > 0.05). Similarly, we did not report a correlation between selenium and C-reactive protein. CONCLUSION: According to our data selenium and CRP may not play a role in progression of coma state in patients with severe traumatic brain injury. The African Field Epidemiology Network 2018-01-16 /pmc/articles/PMC5987113/ /pubmed/29875918 http://dx.doi.org/10.11604/pamj.2018.29.36.10945 Text en © Bahia Belatar et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Belatar, Bahia Laidi, Fatna Abidi, Abdelah El Eljaoudi, Rachid Mamouch, Fouzia Kabbaj, Saad Maazouzi, Wajdi Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
title | Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
title_full | Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
title_fullStr | Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
title_full_unstemmed | Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
title_short | Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
title_sort | serum levels of selenium and c-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987113/ https://www.ncbi.nlm.nih.gov/pubmed/29875918 http://dx.doi.org/10.11604/pamj.2018.29.36.10945 |
work_keys_str_mv | AT belatarbahia serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy AT laidifatna serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy AT abidiabdelahel serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy AT eljaoudirachid serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy AT mamouchfouzia serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy AT kabbajsaad serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy AT maazouziwajdi serumlevelsofseleniumandcreactiveproteinincomatosepatientswithseveretraumaticbraininjuryduringthefirstweekofhospitalizationcasecontrolstudy |